• Certified in Interventional Cardiology
  American Board of Internal Medicine
  1999  (Recertification 2011 – 2021)
• Certified Cardiac Device Specialist (CCDS)
  International Board of Heart Rhythm Examiners (IBHRE)
  Certification Examination for Competency in Cardiac Rhythm Device Therapy for the Physician
  1988
• Certified in Cardiovascular Disease
  American Board of Internal Medicine
  1985
• Certified in Internal Medicine
  American Board of Internal Medicine
  1982

Current Hospital Appointments:

• Los Alamitos Medical Center
  Active staff since April 1985
  3751 Katella Avenue
  Los Alamitos, California 90720
  
  
• MemorialCare Health System
  Long Beach Memorial Medical Center
  Active staff since December 1985
  2801 Atlantic Avenue
  Long Beach, California 90801
  
  
• Lakewood Regional Medical Center
  Active staff since June 1990
  3700 South Street
  Lakewood, California 90712
  

Other Hospital Affiliations:

• Memorial Heart Institute
  Founding Fellow, January 1987
  
  
• University of California, Irvine
  Courtesy Staff since April 1986

• Chairman, Credentials Committee, 1996 – Present
• Member, Governing Board: 1994 – 2001, 2004 – Present
• Chief of Staff, 1994 – 1995
• Vice Chief of Staff, 1993
• Chairman, Quality Assurance Committee, 1993
• Chairman, Critical Care Committee, 1989
• Chairman, Department of Medicine, 1990 – 1992
• Member, Executive Committee, 1989 – Present
• Director Cardiac Catheterization Lab, 1989 – Present
• Director, Pacemaker Clinic, 1985 – Present
• Director, Echocardiography Lab, 1985 – 1997
• Secretary-Treasurer Medical Staff, 1992

• Member, Interventional Cardiology Sub-Committee, 1997 – Present
• Member, Cardiology Credentials and QA Committee, 1996 – Present

• Member, Executive Committee: 2000 – 2001, 2004 – 2007
• Director, Cardiac Catheterization Lab, 2002 – 2005

• American College of Cardiology (FACC)
  Fellow
• American College of Physicians (FACP)
  Fellow
• The Society for Cardiac Angiography and Interventions (FSCAI)
  Fellow
• Heart Rhythm Society-IBHRE CCDS
  Member
• The Society of Geriatric Cardiology (FSGC)
  Fellow

• Co-Director Interventional Fellowship Program
  University of California, Irvine/Long Beach Memorial Hospital
  July 2000 – Present
  
  
• Assistant Clinical Professor of Medicine
  University of California, Irvine
  July 1989 – Present

• Los Alamitos Cardiovascular/Los Alamitos Internal Group, Inc.
  Cardiologist
  Los Alamitos, California
  1985 – Present
  
  
• Fischer Mangold Group
  Emergency Medicine
  St. Francis - St. George Hospital
  Cincinnati, Ohio
  1982 – 1983
  
  
• Medical Health Service
  Staffing Three Cincinnati ER's(Part Time)
  Cincinnati, Ohio
  1980 – 1983
  
  
• Bethesda Hospital
  Critical Care Physician (Part Time)
  Cincinnati, Ohio
  1981 – 1983
  
  

• American Medical Association Physician’s Recognition Award in Continuing Medical Education
  January 2008 – January 2011
  
  
• Sarah Lipson Seigal Memorial Award for Research
  1973

• Kumar P, Agarwal P, VanNatta B, Shandling A, Fischer S, McAtee P, Messenger J. “Clinical evaluation of ThinLine II (models 430-25 and 438-25 Intermedics) bipolar pacing leads.” PACE. 1999; 22 Part II 869.
  
  
• Dabestani A, Takenaka K, Allen B, Gardin J, Fischer S, Russell D, Henry W. “Effects of Spontaneous Respiration on Diastolic Left Ventricular Filling Assessed by Pulsed Doppler Echocardiography.” Am J Cardiol. 1988; 61:1356-1358.

• Cardiovascular Diseases Fellowship
  University of California, Irvine
  Division of Cardiology
  Orange, California
  Walter L. Henry, MD, Chief
  1983 – 1985
  
  
• Internal Medicine Residency
  University of Cincinnati Medical Center
  Department of Internal Medicine
  Cincinnati, Ohio
  Martin Goldberg, MD, Chair
  1980 – 1982
  
  
• Straight Medical Internship
  University of Cincinnati Medical Center
  Department of Internal Medicine
  Cincinnati, Ohio
  Martin Goldberg, MD, Chair
  1979 – 1980
  
  
• Medical Education
  Cornell University Medical College
  New York, New York
  1977 – 1979
  
  
• Medical Education
  Universita di Sassari
  Faculta di Medicinav
  Sassari, Italy
  1973 – 1977
  
  
• Undergraduate Education
  Brooklyn College
  Brooklyn, New York
  BS, Biology, 1969 – 1973

Non-Invasive Cardiology:
Echocardiography – TEE, Dobutamine and Stress Echo.

Invasive-Interventional Cardiovascular and Endovascular Diseases:
Catheterization, PTCA, Atherectomy, Stents, Laser Atherectomy, VBT, Pacing, Peripheral Vascular Disease, Peripheral Interventions, and Current Level II certification for performing and interpreting MDCTA

• SILVER-AMI Risk Stratification in Older Persons with Acute Myocardial Infarction.
  Principal Investigator | 2013 – Present
  Sponsor: Yale University School of Medicine/NIH
  NCT01755052 | http://clinicaltrials.gov/ct2/show/NCT01755052
  
  
• RivaroxAFL3003: An Open Label Study Exploring two treatment strategies in patients with Atrial Fibrillation who undergo Percutaneous Coronary Intervention.
  Sub-Investigator | 2013
  Sponsor:  Janssen Scientific Affairs/Johnson & Johnson
  
  
• Phase III Trial to confirm the Anti-Anginal effect of T-89 in patients with Stable Angina.
  Sub-Investigator | 2013
  Sponsor: Tasly Pharmaceuticals
  NCT0169580 | http://clinicaltrials.gov/ct2/show/NCT01659580
  
  
• Event Driven Trial of weekly Low-Dose Methotrexate in prevention of recurrent cardiovascular events among stable post myocardial infarction patients with Type II Diabetes or Metabolic Syndrome.
  Sub-Investigator | 2013
  Sponsor: Center for Cardiovascular Disease Prevention Brigham and Women’s Hospital/National
  NCT01594333 | http://clinicaltrials.gov/ct2/show/NCT01594333
  
  
• User Comprehension Evaluation of a New Cleaning and Disinfection Procedure for the INRatio® 2 PT/INR Monitoring System (ADAPT) BSTE-0159.
  Sub-Investigator | 2012
  Sponsor: Alere San Diego
  
  
• Mission® PT Coagulation Monitoring System Clinical Study.
  Sub-Investigator | 2012
  Sponsor: ACON Laboratories, INC.
  
  
• The "BRIDGE" Trial (1U01HL08675501A1): Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery.
  Sub-Investigator | 2012 – Present
  Sponsor: National Institutes of Health (NIH)-National Heart, Lung and Blood Institute (NHLBI)
  NCT00786474 | http://clinicaltrials.gov/ct2/show/NCT00786474
  
  
• GLORIA-AF 1160.129: Global Registry on Long-Term Oral Anti-thrombotic Treatment in Patients with Atrial Fibrillation Phase II-III.
  Sub-Investigator | 2012 – Present
  Sponsor: Boehringer Ingelheim
  NCT01468701 | http://clinicaltrials.gov/ct2/show/NCT01468701
  
  
• BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes.
  Sub-Investigator | 2010 – 2012
  Sponsor: St. Jude Medical Center
  NCT01062126 | http://clinicaltrials.gov/ct2/show/NCT01062126
  
  
• The PROMISE Trial: PROspective Multicenter Imaging Study for Evaluation of Chest Pain.
  Sub-Investigator | 2010 – Present
  Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
  NCT01174550 | http://clinicaltrials.gov/ct2/show/record/NCT01174550
  
  
• ORBIT-AF I and II: Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
  Sub-Investigator | 2010 – Present
  Sponsor: Janssen Scientific Affairs, LLC
  Collaborator: Duke Clinical Research
  NCT01165710 | http://clinicaltrials.gov/ct2/show/NCT01165710
  NCT01701817 | http://clinicaltrials.gov/ct2/show/NCT01701817
  
  
• RATE: Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population.
  Sub-Investigator | 2008 – 2010
  Sponsor: St. Jude Medical Center
  NCT00837798 | http://clinicaltrials.gov/ct2/show/NCT00837798
  
  
• FREEDOM: A Frequent Optimization Study the Quick Opt ™ Method.
  Sub-Investigator | 2008 – 2010
  Sponsor: St. Jude Medical Center
  NCT00418314 | http://clinicaltrials.gov/ct2/show/NCT00418314
  
  
• ENGAGE: Phase III, randomized, double-blind, double-dummy, parallel group, multi-center, multi-national study for evaluation of efficacy and safety of DU-176b versus Warfarin in subjects with Atrial Fibrillation - Effective Anticoagulation with Xa next Generation in Atrial Fibrillation (ENGAGE - AF TIMI - 48).
  Sub-Investigator | 2009 – Present
  Sponsor: Daiichi Sankyo Pharma Development
  NCT00781391 | http://clinicaltrials.gov/ct2/show/record/NCT00781391
  
  
• Phase III, double-blind, randomized, placebo-controlled, multi-center study evaluating the efficacy and safety of Dalcetrapib on lipids, lipoproteins,apolipoproteins and markers of CV Risk in patients hospitalized for an acute coronary syndrome (ACS) when treatment is initiated within 1 week after an ACS (Dal-ACUTE).
  Sub-Investigator | 2008 – 2012
  Sponsor: F. Hoffmann-La Roche Ltd., Hoffmann-La Roche, Inc. , Roche Global Development.
  NCT01323153 | http://clinicaltrials.gov/ct2/show/NCT01323153
  
  
• Multi-center, randomized, controlled study to investigate the safety and tolerability of Intravenous Ferric Carboxymaltose (FCM) vs. Iron Dextran in treating iron deficiency anemia in subjects who are not dialysis dependent.
  Sub-Investigator | 2007 – 2009
  Sponsor: Luitpold Pharmaceuticals, Inc.
  NCT00704028 | http://clinicaltrials.gov/ct2/show/NCT00704028
  
  
• Echocardiographic Assessment of Mitral Stenosis, Two-Dimensional Echocardiography versus Doppler Pressure Half Time
  Exercise Echocardiography in Coronary Artery Disease
  Doppler Mitral Flow in Various Pathologic States
  Thin-Line Bi-Polar Pacemaker Leads.
  Department of Physiology, Albany Medical College
  Sponsor:  Intermedics

California, New York, Ohio

Rotary 1986 – 1989